Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women.

Turner BJ, Newschaffer CJ, Zhang D, Cosler L, Hauck WW.

Med Care. 2000 Sep;38(9):911-25.

PMID:
10982113
2.

Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis.

Laine C, Newschaffer CJ, Zhang D, Cosler L, Hauck WW, Turner BJ.

Obstet Gynecol. 2000 Feb;95(2):167-73.

PMID:
10674574
3.

Translating clinical trial results into practice: the effect of an AIDS clinical trial on prescribed antiretroviral therapy for HIV-infected pregnant women.

Turner BJ, Newschaffer CJ, Zhang D, Fanning T, Hauck WW.

Ann Intern Med. 1999 Jun 15;130(12):979-86.

PMID:
10383368
4.

Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen.

Turner BJ, Zhang D, Laine C, Pomerantz RJ, Cosler L, Hauck WW.

J Acquir Immune Defic Syndr. 2001 May 1;27(1):20-9.

PMID:
11404516
5.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94.

PMID:
11981365
6.

HIV infection and zidovudine use in childbearing women.

Sia J, Paul S, Martin RM, Cross H.

Pediatrics. 2004 Dec;114(6):e707-12. Epub 2004 Nov 15.

PMID:
15545619
7.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
8.

Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.

Martí C, Peña JM, Bates I, Madero R, de José I, Pallardo LF, Arribas JR, Gonzalez-Garcia J, Gonzalez A, Vazquez JJ.

Acta Obstet Gynecol Scand. 2007;86(4):409-15.

PMID:
17486461
9.

Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.

Mellins CA, Chu C, Malee K, Allison S, Smith R, Harris L, Higgins A, Zorrilla C, Landesman S, Serchuck L, Larussa P.

AIDS Care. 2008 Sep;20(8):958-68. doi: 10.1080/09540120701767208.

PMID:
18608073
10.

Adherence among women with HIV infection in Puerto Rico: the potential use of modified directly observed therapy (MDOT) among pregnant and postpartum women.

Ciambrone D, Loewenthal HG, Bazerman LB, Zorilla C, Urbina B, Mitty JA.

Women Health. 2006;44(4):61-77.

PMID:
17456464
11.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
12.

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG; Pediatric Spectrum of HIV Disease Consortium.

Pediatrics. 2007 Apr;119(4):e900-6. Epub 2007 Mar 12.

PMID:
17353299
13.
14.

Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.

Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV.

Ann Intern Med. 2002 Sep 3;137(5 Pt 2):381-433.

PMID:
12617573
15.
16.

Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.

Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.

PLoS Med. 2007 Aug;4(8):e257.

17.

Prenatal care of HIV-infected women: analysis of a large New York State cohort.

Turner BJ, Markson L, Hauck W, Cocroft J, Fanning T.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):371-8.

PMID:
7600104
18.

HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women.

Vaz MJ, Barros SM, Palacios R, Senise JF, Lunardi L, Amed AM, Castelo A.

Int J STD AIDS. 2007 Jan;18(1):28-32.

PMID:
17326859
19.

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L; ANRS French Perinatal Cohort.

AIDS. 2008 Jan 11;22(2):289-99.

PMID:
18097232
20.

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G.

Ann Intern Med. 2007 Apr 17;146(8):564-73.

PMID:
17438315

Supplemental Content

Support Center